UPB

COM:UPSTREAMBIO

Upstream Bio

  • Stock

Last Close

18.01

21/11 15:19

Market Cap

965.27M

Beta: -

Volume Today

76.34K

Avg: -

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory r...Show More

investor of